Demographics (1)
- SEX - Biological sex (phv00510383.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00510392.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00510391.v1.p1)
- CD45_FACS_SORTED - Sample was sorted by CD45+ FACS (phv00510389.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00510382.v1.p1)
- GEO_ACCESSION - GEO accession ID (GSM#) (phv00510387.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00510394.v1.p1)
- IS_CELLLINE - Sample comes from cell line (phv00510398.v1.p1)
- IS_TUMOR - Tumor status (phv00510393.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00510395.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00510396.v1.p1)
- SAMPLE_ID - Sample ID (phv00510388.v1.p1)
- SAMPLE_ID - Sample ID (phv00510385.v1.p1)
- SAMPLE_ID - Sample ID (phv00510386.v1.p1)
- SEQUENCING - Sequencing technique (phv00510390.v1.p1)
- SUBJECT_ID - Subject ID (phv00510381.v1.p1)
- SUBJECT_ID - Subject ID (phv00510384.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00510397.v1.p1)